Yang Liu
Directeur/Membre du Conseil chez Hrain Biotechnology Co., Ltd.
Profil
Yang Liu currently works at Hrain Biotechnology Co., Ltd., as Director from 2021.
Mr. Liu received his graduate degree in 2018 from Shanghai University of Finance & Economics.
Postes actifs de Yang Liu
| Sociétés | Poste | Début |
|---|---|---|
Hrain Biotechnology Co., Ltd.
 Hrain Biotechnology Co., Ltd. BiotechnologyHealth Technology Hrain Biotechnology Co., Ltd. engages in the research and development, and production of immune cell therapy products. It offers chimeric antigen receptor (CAR) T-cell therapy, chimeric antigen receptor-transduced natural killer (CAR-NK) cell therapy, dash chimeric antigen receptor (CAR) T-cell therapy. The company was founded by Pin Wang on July 20, 2015 and is headquartered in Shanghai, China. | Directeur/Membre du Conseil | 18/06/2021 |
Formation de Yang Liu
| Shanghai University of Finance & Economics | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Hrain Biotechnology Co., Ltd.
Hrain Biotechnology Co., Ltd. BiotechnologyHealth Technology Hrain Biotechnology Co., Ltd. engages in the research and development, and production of immune cell therapy products. It offers chimeric antigen receptor (CAR) T-cell therapy, chimeric antigen receptor-transduced natural killer (CAR-NK) cell therapy, dash chimeric antigen receptor (CAR) T-cell therapy. The company was founded by Pin Wang on July 20, 2015 and is headquartered in Shanghai, China. | Health Technology |
